Washington Trust Bank’s Alkermes ALKS Stock Holding History

Washington Trust Bank’s Portfolio ALKS Stock Details ALKS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-21	Closed	-$1K	–	690
2016 Q4	$1K	Hold	21	–	–	﹤0.01%	722
2016 Q3	$1K	Buy	+21	New	+$999	﹤0.01%	804

Other funds holding ALKS

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

WIM

Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Washington Trust Bank's ALKS Position: Q1 2017 in Review

Washington Trust Bank sold out of Alkermes (ALKS) in Q1 2017, closing a stake of 21 shares — an estimated $1K sold.

Washington Trust Bank first reported a position in ALKS in Q3 2016 and held it in 2 quarters. The position peaked at $1K in Q4 2016. 262 funds tracked by Wall St. Rank hold ALKS as of Q1 2017.

Washington Trust Bank reported no remaining Alkermes position as of Q1 2017 after selling out during the quarter.
Washington Trust Bank sold 21 Alkermes shares in Q1 2017, an estimated $1K.
Washington Trust Bank first reported a position in Alkermes in Q3 2016 and held it in 2 quarters.
Washington Trust Bank's Alkermes position peaked at $1K in Q4 2016.
262 funds tracked by Wall St. Rank held Alkermes as of Q1 2017.

Based on Washington Trust Bank's 13F filing for Q1 2017, filed 18 Apr 2017.